Accessibility Menu
 
Poolbeg Pharma Plc logo

Poolbeg Pharma Plc

(LSE) POLB

Current Price$4.20
Market Cap$2.96B
Since IPO (2021)-61%
5 YearN/A
1 Year+56%
1 Month+2%

Poolbeg Pharma Plc Financials at a Glance

Market Cap

$2.96B

Revenue (TTM)

$0.00

Net Income (TTM)

$10.09M

EPS (TTM)

$-1.14

P/E Ratio

-3.68

Dividend

$0.00

Beta (Volatility)

-0.04 (Low)

Price

$4.20

Volume

1,961,588

Open

$4.20

Previous Close

$4.20

Daily Range

$4.10 - $4.30

52-Week Range

$2.40 - $5.20

POLB News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Poolbeg Pharma Plc

Industry

Pharmaceuticals

CEO

Jeremy Skillington, PhD

Headquarters

London, E1 2AX, GB

POLB Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-47%

Return on Capital

-54%

Return on Assets

-46%

Earnings Yield

-27.17%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.96B

Shares Outstanding

705.10M

Volume

1.96M

Short Interest

0.00%

Avg. Volume

1.29M

Financials (TTM)

Gross Profit

$114.00K

Operating Income

$6.62M

EBITDA

$6.00M

Operating Cash Flow

$4.65M

Capital Expenditure

$129.00K

Free Cash Flow

$4.78M

Cash & ST Invst.

$7.82M

Total Debt

$0.00

Poolbeg Pharma Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$26.00K

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$2.96B

N/A

Market Cap/Employee

$197.43M

N/A

Employees

15

N/A

Net Income

$2.18M

-20.3%

EBITDA

$2.21M

-22.7%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$9.96M

-29.5%

Accounts Receivable

$738.00K

+1.9%

Inventory

$0.00

+100.0%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-46.19%

N/A

Return on Invested Capital

-53.65%

N/A

Free Cash Flow

$2.35M

-13.2%

Operating Cash Flow

$2.35M

-16.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HEMO.LHemogenyx Pharmaceuticals Plc
$960.00-0.57%
AREC.LArecor Therapeutics plc
$64.50+0.00%
NCYT.LNovacyt S.A.
$33.00-1.49%
SAR.LSareum Holdings plc
$16.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61+0.02%
NOKNokia
$9.46-0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$6.44-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$49.17+0.00%

Questions About POLB

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.